U.S. Department of Defense Invests In Prostrate Cancer Treatment
Filed under: Business Line, Companies, Congress, Contract Awards, Department of Defense, Events, Federal Budget Process, S&T, SRI International, Services, development program
The U.S. Department of Defense/Prostrate Cancer Research Program (DoD/PCRP) gave a grant of just over $1.5 million dollars to SRI International to support pre-clinical studies of the non-profit organization’s agents that might be able to develop into drugs to treat prostate cancer. This grant follows an earlier one that had led to some positive results utilizing plant products.
The U.S. defense budget contains a great deal of novel R&D efforts and a lot of funding. Congress has used it to fund breast and other cancer and disease prevention and treatment research. Obviously the military has a great deal invested in their human capital and medical treatment and this funding helps in those areas. SRI International is a spin-off of Stanford University specializing in sponsored research for government, businesses and foundations.
-
Search This Site
Custom Search -
Recent Posts
- EADS-NA Says Not Comfortable Priming KC-X Contract
- U.S.M.C. Gives Support Contract To Force Protection
- Spirit AeroSystems Named to Boeing Tanker Supplier Team — Press Release
- GTEC Wins $18.7 Million Award to Provide Expeditionary Field Feeding Units to U.S. Army — Press Release
- Contracts for March 11, 2010
-
-
-
-
-
FREE Business Downloads
-
Latest Defense News
More Defense News -->
-
Content from our trusted partner BNETGet your own CBS Interactive Widget.>GET IT NOW
get your job site
at simplyhired.com
